These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 14446408)

  • 21. Studies on headache. The responses of the bulbar conjunctival blood vessels during induced oliguria and diuresis, and their modification by UML-491.
    DALESSIO DJ; CHAPMAN LF; ZILELI T; CATTELL M; EHRLICH R; FORTUIN F; GOODELL H; WOLFF HG
    Arch Neurol; 1961 Dec; 5():590-3. PubMed ID: 13883199
    [No Abstract]   [Full Text] [Related]  

  • 22. Some vascular actions of 1-methyl-d-lysergic acid butanolamide with special reference to its reflex-blocking and antiserotonin actions.
    GEBBER GL; BECK L
    Med Bull (Ann Arbor); 1963; 29():182-94. PubMed ID: 13946952
    [No Abstract]   [Full Text] [Related]  

  • 23. [INTRAVASCULAR ERYTHROCYTE AGGREGATION AND D-1 METHYL-LYSERGIC ACID BUTANOLAMIDE (DESERRIL OR UML 491)].
    PIOVELLA C; DESILVESTRI A
    Cuore Circ; 1963 Aug; 47():179-85. PubMed ID: 14084723
    [No Abstract]   [Full Text] [Related]  

  • 24. [Chemical structure and lysergic acid derivative psychoses].
    SOLMS H
    Praxis; 1956 Aug; 45(32):746-9. PubMed ID: 13359249
    [No Abstract]   [Full Text] [Related]  

  • 25. [Blockade of dextran-anuria in water deprived rats through the serotonin antagonists lysergic acid diethylamide and 1-methyl-lysergic acid butanolamide].
    Taborsky J
    Med Pharmacol Exp Int J Exp Med; 1967; 17(1):6-10. PubMed ID: 6072683
    [No Abstract]   [Full Text] [Related]  

  • 26. Relationships of psychotomimetic to anti-serotonin potencies of congeners of lysergic acid diethylamide (LSD-25).
    ISBELL H; MINER EJ; LOGAN CR
    Psychopharmacologia; 1959; 1():20-8. PubMed ID: 14405872
    [No Abstract]   [Full Text] [Related]  

  • 27. Oxytocic effect of some d-lysergic acid cycloalkylamides.
    VOTAVA Z; PODVALOVA I; SEMONSKY M
    Nature; 1957 Mar; 179(4557):474-5. PubMed ID: 13407748
    [No Abstract]   [Full Text] [Related]  

  • 28. [UML-491 (1-methyl-D-lysergic acid butanolamide) in the prevention and treatment of migraine and other types of headache].
    DOMINGUEZ LAZARO AR; SASTRE CASTILLO A; PEREZ GUERRERO J; CALLEJA CANELAS JL
    Rev Clin Esp; 1962 Dec; 87():273-7. PubMed ID: 14028530
    [No Abstract]   [Full Text] [Related]  

  • 29. [Considerations on the mechanism of action of lysergic acid diethylamine].
    BARBOLINI G; TONINI G
    Boll Soc Ital Biol Sper; 1956; 32(1-2):25-6. PubMed ID: 13374001
    [No Abstract]   [Full Text] [Related]  

  • 30. A central nervous system effect of a nonhallucinatory lysergic acid derivative.
    SPIRTES MA; GUTH PS; POLLEY EH
    Experientia; 1958 Nov; 14(11):428. PubMed ID: 13609622
    [No Abstract]   [Full Text] [Related]  

  • 31. Lysergic acid diethylamide (LSD-25) antagonists. II. Development of tolerance in man to LSD-25 by prior administration of MLD-41 (1-methyl-d-lysergic acid diethylamide).
    ABRAMSON HA; SKLAROFSKY B; BARON MO; FREMONT-SMITH N
    AMA Arch Neurol Psychiatry; 1958 Feb; 79(2):201-7. PubMed ID: 13497364
    [No Abstract]   [Full Text] [Related]  

  • 32. Blockade of depressor responses to serotonin and tryptamine by lysergic acid derivatives in the chicken.
    BUNAG RD; WALASZEK EJ
    Arch Int Pharmacodyn Ther; 1962 Jan; 135():142-51. PubMed ID: 13874645
    [No Abstract]   [Full Text] [Related]  

  • 33. Production of a new lysergic acid derivative in submerged culture by a strain of Claviceps paspali Stevens & Hall.
    ARCAMONE F; CHAIN EB; FERRETTI A; MINGHETTI A; PENNELLA P; TONOLO A; VERO L
    Proc R Soc Lond B Biol Sci; 1961 Oct; 155():26-54. PubMed ID: 14036841
    [No Abstract]   [Full Text] [Related]  

  • 34. The antagonism between 5-hydroxytryptamine and certain derivatives of lysergic acid.
    SAVINI EC
    Br J Pharmacol Chemother; 1956 Sep; 11(3):313-7. PubMed ID: 13364207
    [No Abstract]   [Full Text] [Related]  

  • 35. Displacement of specific serotonin and lysergic acid diethylamide binding by Ergalgin, a new antiserotonin drug.
    Oelszner W
    Acta Biol Med Ger; 1980; 39(8-9):897-901. PubMed ID: 7282219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies in headache: further analysis of the mode of action of UML-491 and its relevance to the nature of vascular headache of the migraine type.
    DALESSIO DJ; CAMP WA; GOODELL H; WOLFF HG
    Trans Am Neurol Assoc; 1961; 86():95-8. PubMed ID: 13883198
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of tryptophan and methyltryptophans on submerged lysergic acid fermentation by Claviceps paspali Stevens and Hall.
    ARCAMONE F; CHAIN EB; FERRETTI A; MINGHETTI A; PENNELLA P; TONOLO A
    Biochim Biophys Acta; 1962 Feb; 57():174-6. PubMed ID: 13862059
    [No Abstract]   [Full Text] [Related]  

  • 38. Studies on headache. The mode of action of UML-491 and its relevance to the nature of vascular headache of the migraine type.
    DALESSIO DJ; CAMP WA; GOODELL H; WOLFF HG
    Arch Neurol; 1961 Mar; 4():235-40. PubMed ID: 13719415
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of lysergic acid derivatives and antihistamines as inhibitors of the edema provoked in the rat's paw by serotonin.
    DOEPFNER W; CERLETTI A
    Int Arch Allergy Appl Immunol; 1958; 12(1-2):89-97. PubMed ID: 13549054
    [No Abstract]   [Full Text] [Related]  

  • 40. ANTIMESCALINE PROPERTIES OF SOME LYSERGIC ACID DERIVATIVES.
    BORSY J; HUSZTI Z; FEKETE M
    Int J Neuropharmacol; 1963 Dec; 2():273-7. PubMed ID: 14119487
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.